June 10, 2026
,
12 PM ET
Featuring investigators from Yale and Johns Hopkins, this session provides an inside look at the clinical experience of MEAI.
Learn More
January 26, 2022
Clearmind’s Management Team Explained the Process Required by the FDA to Approve Clearmind’s MEAI as Medicine
Learn More
December 8, 2021
Clearmind’s Management Answers Questions Related to the Potential Treatment for Alcohol Use Disorder
Learn More
October 20, 2021
In this panel we discussed new treatments for Alcohol Use Disorder and Clearmind's MEAI candidate treatment.
Learn More
